Universe Pharmaceuticals Inc (UPC) has a current Price-to-Book (P/B) ratio of 0.04. Compared to its 3-year average P/B ratio of 0.15, the current P/B ratio is approximately -71.89% higher. Relative to its 5-year average P/B ratio of 0.38, the current P/B ratio is about -88.77% higher. Universe Pharmaceuticals Inc (UPC) has a Forward Free Cash Flow (FCF) yield of approximately -204.39%. Compared to its 3-year average FCF yield of -202.49%, the current FCF yield is approximately 0.94% lower. Relative to its 5-year average FCF yield of -129.87%, the current FCF yield is about 57.39% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for UPC competitors is 1.07, providing a benchmark for relative valuation. Universe Pharmaceuticals Inc Corp (UPC.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of UPC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of UPC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is UPC currently overvalued or undervalued?

What is Universe Pharmaceuticals Inc (UPC) fair value?

UPC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Universe Pharmaceuticals Inc (UPC) is between to according to relative valuation method.

How does UPC's valuation metrics compare to the industry average?

The average P/S ratio for UPC's competitors is 1.07, providing a benchmark for relative valuation. Universe Pharmaceuticals Inc Corp (UPC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Universe Pharmaceuticals Inc (UPC) as of Mar 03 2026?

As of Mar 03 2026, Universe Pharmaceuticals Inc (UPC) has a P/B ratio of 0.04. This indicates that the market values UPC at 0.04 times its book value.

What is the current FCF Yield for Universe Pharmaceuticals Inc (UPC) as of Mar 03 2026?

As of Mar 03 2026, Universe Pharmaceuticals Inc (UPC) has a FCF Yield of -204.39%. This means that for every dollar of Universe Pharmaceuticals Inc's market capitalization, the company generates -204.39 cents in free cash flow.

What is the current Forward P/E ratio for Universe Pharmaceuticals Inc (UPC) as of Mar 03 2026?

As of Mar 03 2026, Universe Pharmaceuticals Inc (UPC) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Universe Pharmaceuticals Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Universe Pharmaceuticals Inc (UPC) as of Mar 03 2026?

As of Mar 03 2026, Universe Pharmaceuticals Inc (UPC) has a Forward P/S ratio of 0.00. This means the market is valuing UPC at $0.00 for every dollar of expected revenue over the next 12 months.

UPC Valuation